CoChat

Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification: A Cohort Study

Kavousi, Maryam, Elias-Smale, Suzette, Rutten, Joost H.W., Leening, Maarten J.G., Vliegenthart, Rozemarijn, Verwoert, Germaine C., Krestin, Gabriel P., Oudkerk, Matthijs, de Maat, Moniek P.M., Leebeek, Frank W.G., Mattace-Raso, Francesco U.S., Lindemans, Jan, Hofman, Albert, Steyerberg, Ewout W., van der Lugt, Aad, van den Meiracker, Anton H., Witteman, Jacqueline C.M. · 2012 · Annals of Internal Medicine

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Whether newer risk markers for coronary heart disease (CHD) improve CHD risk prediction remains unclear. OBJECTIVE: To assess whether newer risk markers for CHD risk prediction and stratification improve Framingham risk score (FRS) predictions. DESIGN: Prospective population-based study. SETTING: The Rotterdam Study, Rotterdam, the Netherlands. PARTICIPANTS: 5933 asymptomatic, community-dwelling participants (mean age, 69.1 years [SD, 8.5]). MEASUREMENTS: Traditional CHD risk factors used in the FRS (age, sex, systolic blood pressure, treatment of hypertension, total and high-density lipoprotein cholesterol levels, smoking, and diabetes) and newer CHD risk factors (N-terminal fragment of prohormone B-type natriuretic peptide levels, von Willebrand factor antigen levels, fibrinogen levels, chronic kidney disease, leukocyte count, C-reactive protein levels, homocysteine levels, uric acid levels, coronary artery calcium [CAC] scores, carotid intima-media thickness, peripheral arterial disease, and pulse wave velocity). RESULTS: Adding CAC scores to the FRS improved the accuracy of risk predictions (c-statistic increase, 0.05 [95% CI, 0.02 to 0.06]; net reclassification index, 19.3% overall [39.3% in those at intermediate risk, by FRS]). Levels of N-terminal fragment of prohormone B-type natriuretic peptide also improved risk predictions but to a lesser extent (c-statistic increase, 0.02 [CI, 0.01 to 0.04]; net reclassification index, 7.6% overall [33.0% in those at intermediate risk, by FRS]). Improvements in predictions with other newer markers were marginal. LIMITATION: The findings may not be generalizable to younger or nonwhite populations. CONCLUSION: Among 12 CHD risk markers, improvements in FRS predictions were most statistically and clinically significant with the addition of CAC scores. Further investigation is needed to assess whether risk refinements using CAC scores lead to a meaningful change in clinical outcome. Whether to use CAC score screening as a more routine test for risk prediction requires full consideration of the financial and clinical costs of performing versus not performing the test for both persons and health systems. PRIMARY FUNDING SOURCE: Netherlands Organization for Health Research and Development (ZonMw).

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-156-6-201203200-00006

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 45 references

Cited by

See all 360

Metadata

Authors
Kavousi, M., Elias-Smale, S., Rutten, J. H. W., Leening, M. J. G., Vliegenthart, R., Verwoert, G. C., Krestin, G. P., Oudkerk, M., de Maat, M. P. M., Leebeek, F. W. G., Mattace-Raso, F. U. S., Lindemans, J., Hofman, A., Steyerberg, E. W., van der Lugt, A., van den Meiracker, A. H., & Witteman, J. C. M.
Affiliations
  • University Medical Center Groningen (NL)
  • From Erasmus University Medical Center, Rotterdam, and University Medical Center Groningen, Groningen, the Netherlands.
Venue
Annals of Internal Medicine
Published
2012-03-20
Volume
156
Issue
6
Pages
438-444
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2159499116
Cited by
360
References
45
Citations by year
2026: 2 · 2025: 6 · 2024: 12 · 2023: 14 · 2022: 21 · 2021: 20 · 2020: 26 · 2019: 19 · 2018: 24 · 2017: 27 · 2016: 37 · 2015: 48 · 2014: 39 · 2013: 45 · 2012: 18
FWCI
48.98
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Annals of Internal Medicine
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
Keywords
coronary artery disease, cardiovascular risk prediction, Framingham risk score, coronary artery calcium, N-terminal proBNP, von Willebrand factor, fibrinogen, C-reactive protein, homocysteine, uric acid, carotid intima-media thickness, pulse wave velocity, peripheral arterial disease, risk stratification, net reclassification improvement
MeSH terms
Aged, Coronary Artery Disease, Coronary Vessels, Female, Humans, Male, Middle Aged, Peptide Fragments, Prospective Studies, Risk Factors, Biomarkers, Incidence, Risk Assessment, Natriuretic Peptide, Brain, Vascular Calcification

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification: A Cohort Study. https://app.cochat.ai/papers/10.7326/0003-4819-156-6-201203200-00006
The paper
Kavousi, M., Elias-Smale, S., Rutten, J. H. W., Leening, M. J. G., Vliegenthart, R., Verwoert, G. C., Krestin, G. P., Oudkerk, M., de Maat, M. P. M., Leebeek, F. W. G., Mattace-Raso, F. U. S., Lindemans, J., Hofman, A., Steyerberg, E. W., van der Lugt, A., van den Meiracker, A. H., & Witteman, J. C. M. (2012). Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification: A Cohort Study. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-156-6-201203200-00006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.